To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Intercell lands E30m blue chip round
Austrian vaccine developer Intercell has completed one of the largest European venture capital funding rounds of 2003, with Apax, Nomura and NIB Capital among the investors.
